Shopping Cart
- Remove All
 Your shopping cart is currently empty Your shopping cart is currently empty
Anti-MMP-2 Antibody (3D181) is a Mouse antibody targeting MMP-2. Anti-MMP-2 Antibody (3D181) can be used in ELISA,FCM.
| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 20 μL | $69 | 7-10 days | |
| 100 μL | $199 | 7-10 days | 
| Description | Anti-MMP-2 Antibody (3D181) is a Mouse antibody targeting MMP-2. Anti-MMP-2 Antibody (3D181) can be used in ELISA,FCM. | 
| Synonyms | MMP-2, matrix metallopeptidase 2, GelA, Clg4a | 
| Ig Type | Mouse IgG2a | 
| Clone | 3D181 | 
| Reactivity | Human | 
| Specificity | Human MMP-2 No cross-reactivity in ELISA with Human MMP1 Human MMP7 Human MMP9 Human cell lysate (293 cell line) | 
| Verified Activity | Flow cytometric analysis of Human MMP2 expression on MG63 cells. The cells were treated according to manufacturer’s manual (BD Pharmingen™ Cat. No. 554714), stained with purified anti-Human MMP2, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. | 
| Application | |
| Recommended Dose | ELISA: 1:5000-1:10000; FCM: 1:25-1:100 | 
| Antibody Type | Monoclonal | 
| Host Species | Mouse | 
| Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human MMP-2 (rh MMP-2; TMPY-01477; NP_004521.1; Met 1-Cys660). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. | 
| Purification | Protein A | 
| Appearance | Liquid | 
| Formulation | 0.2 μm filtered solution in PBS with 10% Trehalose, pH7.0 | 
| Research Background | Matrix Metalloproteinase-2 (MMP-2) is an enzyme that degrades components of the extracellular matrix and thus plays a pivotal role in cell migration during physiological and pathological processes. MMP-2 expression is dependent on extracellular matrix metalloproteinase inducer (EMMPRIN), Her2/neu, growth factors, cytokines, and hormones. Pro-MMP-2 activation needs MT1-MMP and TIMP-2 contribution. MMP-2 is changed in distribution and increased in amount in the ventral cochlear nucleus after unilateral cochlear ablation. A low level of MMP-2 is linked to a favorable prognosis in patients with a hormone receptor-negative tumor, usually associated with high risk. As a zymogen requiring proteolytic activation for catalytic activity, MMP-2 has been implicated broadly in the invasion and metastasis of many cancer model systems, including human breast cancer (HBC). Blocking MMP-2 secretion and activation during breast carcinoma development may decrease metastasis. The detection of active MMP-2 alone or the rate of pro-MMP-2 and active MMP-2 is considered a very sensitive indicator of cancer metastasis. Modulation of MMP-2 expression and activation through specific inhibitors and activators may thus provide a new mechanism for breast cancer treatment. | 
| Conjucates | Unconjugated | 
| Immunogen | Recombinant Protein: Human MMP-2 protein (TMPY-01477) | 
| Antigen Species | Human | 
| Biology Area | Cancer Drug Targets | 
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. | 
| Transport | Shipping with blue ice. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.